Proto Labs, Inc. PRLB
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 154.32M | 149.34M | 139.34M | 136.49M | 135.37M |
| Total Other Revenue | -- | -- | -- | -- | 209.00K |
| Total Revenue | 154.32M | 149.34M | 139.34M | 136.49M | 135.37M |
| Cost of Revenue | 85.66M | 80.00M | 75.74M | 76.12M | 74.07M |
| Gross Profit | 68.66M | 69.34M | 63.59M | 60.37M | 61.29M |
| SG&A Expenses | 42.77M | 45.33M | 41.79M | 42.31M | 41.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 139.44M | 136.12M | 128.08M | 128.75M | 126.52M |
| Operating Income | 14.88M | 13.22M | 11.26M | 7.74M | 8.85M |
| Income Before Tax | 16.21M | 12.60M | 11.32M | 8.15M | 10.25M |
| Income Tax Expenses | 4.45M | 3.45M | 3.21M | 2.15M | 3.04M |
| Earnings from Continuing Operations | 11.76M | 9.15M | 8.11M | 6.00M | 7.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.76M | 9.15M | 8.11M | 6.00M | 7.22M |
| EBIT | 14.88M | 13.22M | 11.26M | 7.74M | 8.85M |
| EBITDA | 20.28M | 21.31M | 19.33M | 16.19M | 17.28M |
| EPS Basic | 0.49 | 0.38 | 0.34 | 0.25 | 0.30 |
| Normalized Basic EPS | 0.43 | 0.38 | 0.33 | 0.24 | 0.27 |
| EPS Diluted | 0.48 | 0.37 | 0.33 | 0.25 | 0.30 |
| Normalized Diluted EPS | 0.43 | 0.37 | 0.33 | 0.24 | 0.27 |
| Average Basic Shares Outstanding | 24.02M | 23.97M | 23.84M | 23.76M | 23.89M |
| Average Diluted Shares Outstanding | 24.44M | 24.42M | 24.29M | 24.17M | 24.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |